Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer. | Ther Adv Med Oncol | 2026 | 41487693 | PubTator, text mining | PubMed |
| Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1. | J Biol Chem | 2026 | 41349767 | PubTator, text mining | PubMed |
| Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy. | Mol Ther | 2026 | 41338184 | PubTator, text mining | PubMed |
| ROR1 in Endometrial Carcinoma: Correlation With Clinicopathological Features, Survival, and Prognosis. | Biotechnol Appl Biochem | 2026 | 41318958 | PubTator, text mining | PubMed |
| Anti-NSCLC efficacy of a novel ROR1/PI3Kα/BRD4 multi-target inhibitor. | Bioorg Med Chem | 2026 | 41240398 | PubTator, text mining | PubMed |
| Peripheral blood plasmablasts, a potential confounder in chronic lymphocytic leukemia measureable residual disease analysis. | Cytometry B Clin Cytom | 2026 | 41186049 | PubTator, text mining | PubMed |
| Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma. | Mol Ther | 2026 | 41137393 | PubTator, text mining | PubMed |
| Immunophenotypic, cytogenetic, and mutational features of chronic lymphocytic leukemia/small lymphocytic lymphoma with atypical immunophenotype. | Cytometry B Clin Cytom | 2026 | 40814768 | PubTator, text mining | PubMed |
| Downregulation of RORl via STAT3 and P300 Promotes P38 Pathway- Dependent Lens Epithelial Cells Apoptosis in Age-Related Cataract. | Biochem Genet | 2026 | 40019609 | PubTator, text mining | PubMed |
| Dysregulated Kinase Expression in Teratozoospermia and Implications for Male Infertility: An Integrated Gene Expression Study. | J Reprod Infertil | 2025 | 42038773 | PubTator, text mining | PubMed |
| CAR-T therapy: Advances in respiratory diseases. | Chin Med J Pulm Crit Care Med | 2025 | 41551012 | PubTator, text mining | PubMed |
| Abstracts of the Annual Meeting of the Iuliu HaţieganuUniversity of Medicine and Pharmacy: 8th - 13th December 2025, Cluj-Napoca. | Med Pharm Rep | 2025 | 41496885 | PubTator, text mining | PubMed |
| A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies. | Front Immunol | 2025 | 41479906 | PubTator, text mining | PubMed |
| In Silico and in vitro Characterization of Lactobacillus acidophilus Bacteriocins as ROR-1-Targeted Therapeutics in Breast Cancer. | Iran J Pharm Res | 2025 | 41477115 | PubTator, text mining | PubMed |
| NKTR-255, a polymer-conjugated IL-15, synergizes with CAR-T cell therapy to activate endogenous anti-tumor immunity and improve tumor control. | bioRxiv | 2025 | 41473276 | PubTator, text mining | PubMed |
| An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target. | Front Pharmacol | 2025 | 41415567 | PubTator, text mining | PubMed |
| Advances in genomic and pharmacokinetic profiling for clinical stratification of metastatic breast cancer. | Discov Oncol | 2025 | 41369820 | PubTator, text mining | PubMed |
| Integration of genetic, proteomic, and transcriptomic data identifies therapeutic targets and prognostic biomarkers in bladder cancer. | Transl Androl Urol | 2025 | 41368242 | PubTator, text mining | PubMed |
| High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma. | Exp Dermatol | 2025 | 41355329 | PubTator, text mining | PubMed |
| 18F-/68Ga-Labeled Peptide-Based Probes for PET Imaging of ROR1 Expression. | J Med Chem | 2025 | 41351548 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=4